MX2020009204A - Una forma de dosificacion oral solida farmaceutica de solifenacina. - Google Patents

Una forma de dosificacion oral solida farmaceutica de solifenacina.

Info

Publication number
MX2020009204A
MX2020009204A MX2020009204A MX2020009204A MX2020009204A MX 2020009204 A MX2020009204 A MX 2020009204A MX 2020009204 A MX2020009204 A MX 2020009204A MX 2020009204 A MX2020009204 A MX 2020009204A MX 2020009204 A MX2020009204 A MX 2020009204A
Authority
MX
Mexico
Prior art keywords
solifenacin
dosage form
solid oral
oral dosage
pharmaceutical solid
Prior art date
Application number
MX2020009204A
Other languages
English (en)
Inventor
Villarreal Ana Purón
Munárriz Ainara Lecumberri
Original Assignee
Intas Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intas Pharmaceuticals Ltd filed Critical Intas Pharmaceuticals Ltd
Publication of MX2020009204A publication Critical patent/MX2020009204A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Physiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención se refiere a una forma de dosificación oral sólida farmacéutica de solifenacina o una sal farmacéuticamente aceptable de la misma, una resina de intercambio iónico, y uno o más excipientes o vehículos farmacéuticamente aceptables, en la que la solifenacina y la resina de intercambio iónico forman una matriz y la forma de dosificación presenta un perfil de disolución de acuerdo con el que: (i) después de 5 minutos a pH de 6.5 a 7.5, menos de un 10% p/p del contenido de solifenacina se disuelve, y (ii) después de 30 minutos a pH de 1.0 a 1.6, más de un 80% p/p del contenido de solifenacina se disuelve. También se refiere a un procedimiento para su preparación, y el uso de la forma de dosificación oral sólida farmacéutica en el tratamiento de síntomas del tracto urinario inferior asociados con el síndrome de vejiga hiperactiva.
MX2020009204A 2018-03-08 2019-03-07 Una forma de dosificacion oral solida farmaceutica de solifenacina. MX2020009204A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP18382149 2018-03-08
EP18382472 2018-06-26
PCT/EP2019/055666 WO2019170795A1 (en) 2018-03-08 2019-03-07 A pharmaceutical solid oral dosage form of solifenacin

Publications (1)

Publication Number Publication Date
MX2020009204A true MX2020009204A (es) 2021-01-15

Family

ID=65598664

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2020009204A MX2020009204A (es) 2018-03-08 2019-03-07 Una forma de dosificacion oral solida farmaceutica de solifenacina.

Country Status (5)

Country Link
JP (1) JP2021526504A (es)
MX (1) MX2020009204A (es)
TW (1) TW201938163A (es)
UY (1) UY38137A (es)
WO (1) WO2019170795A1 (es)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008128028A2 (en) * 2007-04-11 2008-10-23 Dr. Reddy's Laboratories Ltd. Solifenacin compositions
KR20070010132A (ko) 2004-03-25 2007-01-22 아스텔라스세이야쿠 가부시키가이샤 솔리페나신 또는 그의 염의 고형 제제용 조성물
WO2005105045A1 (ja) 2004-04-30 2005-11-10 Astellas Pharma Inc. 経口投与用時限放出型粒子状医薬組成物及び該組成物を含有する口腔内速崩壊錠
US9918970B2 (en) * 2010-05-19 2018-03-20 Astellas Pharma Inc. Pharmaceutical composition comprising solifenacin

Also Published As

Publication number Publication date
TW201938163A (zh) 2019-10-01
JP2021526504A (ja) 2021-10-07
UY38137A (es) 2019-07-31
WO2019170795A1 (en) 2019-09-12

Similar Documents

Publication Publication Date Title
MX2019012884A (es) Terapia de combinacion.
PT1933833E (pt) Terapia para o tratamento da bexiga superactiva
MX2016010179A (es) Composiciones de donepezilo y métodos para tratar la enfermedad de alzheimer.
NZ714963A (en) Compositions and methods for treating anemia
RU2017116740A (ru) Комбинации для лечения рассеянного склероза
MX2022002196A (es) Composición de liberación retardada de niclosamida y uso antiviral de la misma.
AU2018282104A1 (en) Use of vibegron to treat overactive bladder
RU2017134443A (ru) Способ лечения с применением традипитанта
JP2018090566A5 (es)
JP2017531033A5 (es)
SI2889033T1 (en) Treatment of negative symptoms of schizophrenia with (R) -7-chloro-N- (chonylidin-3-yl) benzo (B) thiophene-2-carboxamide and pharmaceutically acceptable salts thereof
IL300151A (en) Combinations for cancer treatment
MX2021002322A (es) Nuevos metodos.
NZ737561A (en) Oral composition of celecoxib for treatment of pain
PH12021550170A1 (en) Pharmaceutical dosage form which can be adminitered orally and has modified release
JP2018039810A5 (es)
RU2018146504A (ru) Лечение внутрипеченочных холестатических заболеваний
AU2018282105A1 (en) Dosing of vibegron for treatment of overactive bladder
JP2016505050A5 (es)
NZ751972A (en) Treatment of prurigo nodularis
FI3493812T3 (fi) Imetelstaatin ja venetoklaksin yhdistelmiä akuutin myelooisen leukemian hoitoa varten
WO2021242844A8 (en) Grk2 inhibitors and uses thereof
MX2020009204A (es) Una forma de dosificacion oral solida farmaceutica de solifenacina.
CL2023000296A1 (es) Uso de dexpramipexol para el tratamiento del asma moderado a grave
JP2019535830A5 (es)